Half-year report · Q2
6776.TEDINET S100URIX
Period2024-04-01 → 2024-09-30
Filed2024-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥13.7bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Revenue | ¥26.9bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥12.8bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Operating income | ¥291m | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Operating income | ¥502m | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Ordinary income | ¥309m | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥1.3bn | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥726m | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥311m | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥835m | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥174m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥948m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥566m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥203m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Net income | ¥577m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Total assets | ¥30.9bn | at 2024-09-30 | Cons. | Assets |
| Total assets | ¥28.0bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥29.0bn | at 2023-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥19.3bn | at 2024-09-30 | Cons. | Liabilities |
| Total liabilities | ¥17.0bn | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥11.6bn | at 2024-09-30 | Cons. | Net assets |
| Net assets / equity | ¥10.9bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥10.5bn | at 2023-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥6.3bn | at 2024-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥5.2bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥6.4bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.3bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.5bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.6bn | at 2023-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥921m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.7bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.1bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥1.3bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.7bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.7bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥1.4bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥622m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥327m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥10.25 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥55.77 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥33.28 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 31.4% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.1% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 30.0% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 41
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2024-09-30 | −¥25m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2024-09-30 | −¥25m |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-09-30 | ¥2m |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Americareportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥3.5bn |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Americareportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥3.5bn |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Americareportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥116m |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Chinareportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥309m |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Chinareportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥304m |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Chinareportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥4m |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Chinareportable segment | segment profit | 2024-04-01 → 2024-09-30 | −¥3m |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Japanreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥9.8bn |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Japanreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥9.8bn |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Japanreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥21m |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Japanreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥52m |
| jpcrp040300-q2r_E01813-000Real Estate Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥142m |
| jpcrp040300-q2r_E01813-000Real Estate Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥142m |
| jpcrp040300-q2r_E01813-000Real Estate Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥124m |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥13.7bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥13.7bn |
| —segment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥25m |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥289m |
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-09-30 | −¥21m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-09-30 | −¥21m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-09-30 | ¥2m |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Americareportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥2.2bn |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Americareportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥2.2bn |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Americareportable segment | segment profit | 2023-04-01 → 2023-09-30 | −¥2m |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Chinareportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥225m |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Chinareportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥225m |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Chinareportable segment | segment profit | 2023-04-01 → 2023-09-30 | −¥18m |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Japanreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥10.3bn |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Japanreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥10.3bn |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Japanreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥21m |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Japanreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥405m |
| jpcrp040300-q2r_E01813-000Real Estate Businessreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥142m |
| jpcrp040300-q2r_E01813-000Real Estate Businessreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥142m |
| jpcrp040300-q2r_E01813-000Real Estate Businessreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥115m |
| —segment total | revenue | 2023-04-01 → 2023-09-30 | ¥12.9bn |
| —segment total | revenue external | 2023-04-01 → 2023-09-30 | ¥12.8bn |
| —segment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥21m |
| —segment total | segment profit | 2023-04-01 → 2023-09-30 | ¥500m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 493
| Item | Context | Value | Unit |
|---|---|---|---|
| Shareholding ratio | CurrentQuarterInstant_No1MajorShareholdersMember | 0.3357 | |
| Number of shares held | CurrentQuarterInstant_No2MajorShareholdersMember | 2352000 | |
| Shareholding ratio | CurrentQuarterInstant_No2MajorShareholdersMember | 0.1382 | |
| Number of shares held | CurrentQuarterInstant_No3MajorShareholdersMember | 892000 | |
| Shareholding ratio | CurrentQuarterInstant_No3MajorShareholdersMember | 0.0524 | |
| Number of shares held | CurrentQuarterInstant_No4MajorShareholdersMember | 520000 | |
| Shareholding ratio | CurrentQuarterInstant_No4MajorShareholdersMember | 0.0305 | |
| Number of shares held | CurrentQuarterInstant_No5MajorShareholdersMember | 471000 | |
| Shareholding ratio | CurrentQuarterInstant_No5MajorShareholdersMember | 0.0277 | |
| Number of shares held | CurrentQuarterInstant_No6MajorShareholdersMember | 252000 | |
| Shareholding ratio | CurrentQuarterInstant_No6MajorShareholdersMember | 0.0148 | |
| Number of shares held | CurrentQuarterInstant_No7MajorShareholdersMember | 250000 | |
| Shareholding ratio | CurrentQuarterInstant_No7MajorShareholdersMember | 0.0146 | |
| Number of shares held | CurrentQuarterInstant_No8MajorShareholdersMember | 222000 | |
| Shareholding ratio | CurrentQuarterInstant_No8MajorShareholdersMember | 0.0130 | |
| Number of shares held | CurrentQuarterInstant_No9MajorShareholdersMember | 220000 | |
| Shareholding ratio | CurrentQuarterInstant_No9MajorShareholdersMember | 0.0129 | |
| Number of shares held | CurrentQuarterInstant_No10MajorShareholdersMember | 213000 | |
| Shareholding ratio | CurrentQuarterInstant_No10MajorShareholdersMember | 0.0125 | |
| Number of shares held | CurrentQuarterInstant | 11105000 | |
| Shareholding ratio | CurrentQuarterInstant | 0.6527 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 17007300 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 170073 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 6700 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 17014000 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 170073 | |
| Cash and deposits | Prior1YearInstant | 5186000000 | JPY |
| Cash and deposits | CurrentQuarterInstant | 6335000000 | JPY |
| Notes and accounts receivable trade | Prior1YearInstant | 3676000000 | JPY |
| Notes and accounts receivable trade | CurrentQuarterInstant | 4086000000 | JPY |
| Electronically recorded monetary claims operating ca | Prior1YearInstant | 1500000000 | JPY |
| Electronically recorded monetary claims operating ca | CurrentQuarterInstant | 1677000000 | JPY |
| Finished goods | Prior1YearInstant | 813000000 | JPY |
| Finished goods | CurrentQuarterInstant | 836000000 | JPY |
| Work in process | Prior1YearInstant | 204000000 | JPY |
| Work in process | CurrentQuarterInstant | 254000000 | JPY |
| Raw materials | Prior1YearInstant | 1149000000 | JPY |
| Raw materials | CurrentQuarterInstant | 1099000000 | JPY |
| Other ca | Prior1YearInstant | 230000000 | JPY |
| Other ca | CurrentQuarterInstant | 298000000 | JPY |
| Current assets | Prior1YearInstant | 12762000000 | JPY |
| Current assets | CurrentQuarterInstant | 14588000000 | JPY |
| Buildings and structures net | Prior1YearInstant | 5232000000 | JPY |
| Buildings and structures net | CurrentQuarterInstant | 5650000000 | JPY |
| Machinery equipment and vehicles net | Prior1YearInstant | 4156000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |